Free Trial

Dufry (now Avolta) (DUFNSW; Ba2, BB+; S) Cheap view on €27s

CONSUMER CYCLICALS

Cheap view on the €27s at Z+132/OAS+152/B+184 pricing to maturity (2% cpn).

  • Curve has moved wider and steepened recently - driver unclear to us - taking the new 31s back to pricing levels in April at MS+205 (OAS+186 now).
  • The curve is steep; parallel to distressed VFC. That's despite 1) clear financial policies including recent history of deleveraging toward target and 2) expected organic growth in MSD. But counter is this is still a travel exposed retailer running HSD EBITDA margins. 27s traded as low as €75/Z+700 during covid and mid 2022 for e.g. of that beta.
  • Hence we prefer shorter-duration 27s for now. For longer duration travel exposure we don't mind the equal rated new Finnair29s (caution to scale risk to single carrier/country risk) that has government ownership/support and trades north of it at Z+218.
  • We don't expect a revisit to primary markets anytime soon; the new €500m 31s had UoP of paying down the Oct €800m 24s. It tendered ~half of it down, will use proceeds + cash when it rolls off is indication it gave then. We don't rule out supply next year with €600m across revolvers/TL's coming due.
190 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Cheap view on the €27s at Z+132/OAS+152/B+184 pricing to maturity (2% cpn).

  • Curve has moved wider and steepened recently - driver unclear to us - taking the new 31s back to pricing levels in April at MS+205 (OAS+186 now).
  • The curve is steep; parallel to distressed VFC. That's despite 1) clear financial policies including recent history of deleveraging toward target and 2) expected organic growth in MSD. But counter is this is still a travel exposed retailer running HSD EBITDA margins. 27s traded as low as €75/Z+700 during covid and mid 2022 for e.g. of that beta.
  • Hence we prefer shorter-duration 27s for now. For longer duration travel exposure we don't mind the equal rated new Finnair29s (caution to scale risk to single carrier/country risk) that has government ownership/support and trades north of it at Z+218.
  • We don't expect a revisit to primary markets anytime soon; the new €500m 31s had UoP of paying down the Oct €800m 24s. It tendered ~half of it down, will use proceeds + cash when it rolls off is indication it gave then. We don't rule out supply next year with €600m across revolvers/TL's coming due.